Clinical efficacy of liraglutide combined with pioglitazone in obese polycystic ovary syndrome and its effects on the serum chemerin/visfatin ratio
American Journal of Translational Research · 2026 · 18 (6) · 5128-5144
DOI: 10.62347/wndz4386 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Jing Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qingyang People's Hospital No. 608, South Street, Xifeng District, Qingyang 745000, Gansu, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the clinical efficacy and safety of liraglutide combined with pioglitazone in obese patients with polycystic ovary syndrome (PCOS), and to explore the predictive value of serum chemerin, visfatin and their ratio for the improvement of insulin resistance (IR). METHODS: A total of 338 obese PCOS women enrolled in this retrospective study were divided into two groups. The control group (n=168) received pioglitazone alone (15-30 mg/day), while the combination group (n=170) received liraglutide (0.6-1.8 mg/day) plus pioglitazone for 24 weeks. Anthropometric, metabolic, hormonal and adipokine-related indicators were compared before and after treatment. Correlation analysis, ROC curve analysis and multivariate logistic regression analysis were subsequently performed. RESULTS: After treatment, the combination group exhibited significantly better improvements in multiple anthropometric, metabolic, hormonal and adipokine parameters than the control group (all P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Qingyang People's Hospital No. 608, South Street, Xifeng District, Qingyang 745000, Gansu, China.
- Department of Child Healthcare and Rehabilitation, The Second Hospital of Lanzhou University No. 82, Cuiyingmen Street, Chengguan District, Lanzhou 730000, Gansu, China.
- Department of Pharmacy, Qingyang People's Hospital No. 608, South Street, Xifeng District, Qingyang 745000, Gansu, China.
- Department of Clinical Nutrition, Qingyang People's Hospital No. 608, South Street, Xifeng District, Qingyang 745000, Gansu, China.
Zitieren
APA
Zhang, J., Liu, Y., Song, T., Chen, Q., & Han, W. (2026). Clinical efficacy of liraglutide combined with pioglitazone in obese polycystic ovary syndrome and its effects on the serum chemerin/visfatin ratio. American Journal of Translational Research, 18(6), 5128-5144. https://doi.org/10.62347/wndz4386
Vancouver
Zhang J, Liu Y, Song T, Chen Q, Han W. Clinical efficacy of liraglutide combined with pioglitazone in obese polycystic ovary syndrome and its effects on the serum chemerin/visfatin ratio. American Journal of Translational Research. 2026;18(6):5128-5144. doi:10.62347/wndz4386
BibTeX
@article{Zhang2026,
author = {Zhang, Jing and Liu, Yahong and Song, Tao and Chen, Qian and Han, Wenbiao},
title = {Clinical efficacy of liraglutide combined with pioglitazone in obese polycystic ovary syndrome and its effects on the serum chemerin/visfatin ratio},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {6},
pages = {5128--5144},
doi = {10.62347/wndz4386}
}
EUVIMED